Winslow Evans & Crocker’s Tandem Diabetes Care TNDM Stock Holding History

Winslow Evans & Crocker’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$24K	Hold	255	–	–	﹤0.01%	751
2020 Q3	$29K	Hold	255	–	–	0.01%	558
2020 Q2	$25K	Sell	255 -1	-0.4%	-$80	0.01%	571
2020 Q1	$18K	Hold	256	–	–	0.01%	598
2019 Q4	$16K	Hold	256	–	–	﹤0.01%	718
2019 Q3	$16K	Sell	256 -230	-47%	-$14.7K	﹤0.01%	702
2019 Q2	$32K	Hold	486	–	–	0.01%	598
2019 Q1	$32K	Buy	486 +116	+31%	+$6.09K	0.01%	585
2018 Q4	$16K	Hold	370	–	–	0.01%	674
2018 Q3	$16K	Buy	370 +240	+185%	+$8.38K	﹤0.01%	724
2018 Q2	$4K	Buy	+130	New	+$1.6K	﹤0.01%	989

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Winslow Evans & Crocker's TNDM Position: Q4 2020 in Review

Winslow Evans & Crocker held its Tandem Diabetes Care (TNDM) position steady in Q4 2020 at 255 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #751.

Winslow Evans & Crocker first reported a position in TNDM in Q2 2018 and has held it in 11 quarters since. The position peaked at $32K in Q2 2019. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

Winslow Evans & Crocker held 255 shares of Tandem Diabetes Care worth $24K as of Q4 2020.
Winslow Evans & Crocker left its Tandem Diabetes Care share count unchanged in Q4 2020.
Tandem Diabetes Care made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #751 holding.
Winslow Evans & Crocker first reported a position in Tandem Diabetes Care in Q2 2018 and has held it in 11 quarters since.
Winslow Evans & Crocker's Tandem Diabetes Care position peaked at $32K in Q2 2019.
309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.